RPRX Royalty Pharma plc
Price Chart
Executive Summary
Royalty Pharma announced it will report Q1 2026 financial results on May 6, 2026, with no financials released in this press release. The prior quarter (Q4 2025) reported EPS of $1.47, a 21.2% beat versus consensus of $1.21, though revenue was not disclosed here.
Actionable Insight
Traders should monitor the upcoming May 6 earnings call for guidance on Q1 2026 and portfolio performance; absence of current quarter data limits immediate trading impact.
Key Facts
- Company to report Q1 2026 results on May 6, 2026
- No financial data provided for Q1 2026 in this release
- Q4 2025 EPS was $1.47, beating $1.21 consensus by 21.2%
- Revenue for Q4 2025 was not disclosed in this document
- Recent insider selling: $1.6M over past 30 days
Financial Impact
Prior quarter EPS beat by 21.2%; no forward financials provided
Risk Factors
- Lack of current financials reduces immediate analytical value
- Recent insider selling may signal caution despite prior beat
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3274898 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 28, 2026
15d ago
|
Insider Cluster
| $55.76 $55.87 | ▲ +0.20% | ▲ +2.72% | $54.87 (−1.60%) |
|
May 28, 2026
15d ago
|
8-K
| $55.76 $54.97 | ▼ −1.42% | ▼ −1.12% | $54.87 (−1.60%) |
|
May 22, 2026
22d ago
|
Insider Cluster
| $54.50 $55.18 | ▲ +1.25% | ▼ −0.41% | $54.87 (+0.68%) |
|
May 15, 2026
28d ago
|
Insider Cluster
| $52.07 $53.86 | ▲ +3.44% | ▲ +1.82% | $54.87 (+5.38%) |
|
May 14, 2026
29d ago
|
144
| $52.85 $54.50 | ▲ +3.12% | ▲ +2.16% | $54.87 (+3.82%) |
|
May 6, 2026
5w ago
|
8-K
| $50.72 $51.70 | ▲ +1.93% | ▲ +0.80% | $54.87 (+8.18%) |
|
Apr 17, 2026
8w ago
|
Press Release
| $50.00 $49.38 | ▼ −1.24% | ▼ −1.79% | $54.87 (+9.74%) |
|
Apr 15, 2026
8w ago
|
Press Release
| $48.48 $49.64 | ▲ +2.39% | ▲ +1.41% | $54.87 (+13.18%) |
|
Apr 10, 2026
9w ago
|
DEFA14A
| $48.43 $49.30 | ▲ +1.80% | ▼ −1.50% | $54.87 (+13.30%) |
|
Mar 30, 2026
10w ago
|
Press Release
| $46.37 $46.87 | ▲ +1.08% | ▼ −3.22% | $54.87 (+18.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access